return to TMARC

    Publications | Abstracts

Ellis RJ, Peterson S, Cherner M, Morgan E, Schrier R, Tang B, Hoenigl M, Letendre S, Iudicello J.  (2020). Beneficial effects of cannabis on blood brain barrier function in HIV. Clinical Infectious Diseases, Epub Apr 16. PMID: 32296832  
Walter TJ, Young JW, Milienne-Petiot M, Deben DS, Heaton RK, Letendre S, Grelotti DJ, Perry W, Grant I, Minassian A.  (2020). Both HIV and Tat expression decrease prepulse inhibition with further impairment by methamphetamine. Progress in Neuro-psychopharmacology & Biological Psychiatry, Epub Sept 4. PMID: 32891668  
Saloner R, Cherner M, Iudicello JE, Heaton RK, Letendre SL, Ellis RJ.  (2020). Cerebrospinal fluid norepinephrine and neurocognition in HIV and methamphetamine dependence. Journal of Acquired Immune Deficiency Syndromes (1999), 85(2), e12-e22. PMID: 32558666  PMCID: PMC7492443  
Saloner R, Cherner M Sundermann EE, Watson CWM, Iudicello JE, Letendre SL, Kumar A, Ellis RJ.  (2020). COMT Val158met genotype alters the effects of methamphetamine dependence on dopamine and dopamine-related executive function: Preliminary findings. Psychiatry Research, 292, 113269. PMID: 32739643  
Nguyen AL, Sundermann E, Rubtsova AA, Sabbag S Umlauf A, Heaton R Letendre S, Jeste DV, Marquine MJ.  (2020). Emotional health outcomes are influenced by sexual minority identity and HIV serostatus. AIDS Care, Epub Jun 26, 1-6. PMID: 32590909  
Keltner JR, Tong A, Visser E, Jenkinson M, Connolly CG, Dasca A, Sheringov A, Calvo Z, Umbao E, Mande R, Bilder MB, Sahota G, Franklin DR, Corkran S, Grant I, Archibald S, Vaida F, Brown GG, Atkinson JH, Simmons AN, Ellis RJ.  (2020). Evidence for a novel subcortical mechanism for posterior cingulate cortex atrophy in HIV peripheral neuropathy. Journal of Neurovirology, 26(4), 530-543. PMID: 32524422  PMCID: PMC7442648  
Saloner R, Paolillo EW, Kohli M, Murray SS, Moore DJ, Grant I, Cherner M.  (2020). Genetic variation in alcohol dehydrogenase is associated with neurocognition in men with HIV and history of acohol use disorder: Preliminary findings. Journal of Neurovirology, 26(2), 214-225. PMID: 31933193  PMCID: PMC7261244  
Saloner R, Cherner M, Grelotti DJ, Paolillo EW, Moore DJ, Heaton RK, Letendre SL, Kumar A, Grant I, Ellis RJ.  (2020). Lower CSF homovanillic acid relates to higher burden of neuroinflammation and depression in people with HIV disease. Brain, Behavior, And Immunity, Epub Sept 20. PMID: 32966871  
Saloner R, Fields JA, Marcondes MCG, Iudicello JE, von Kanel S, Cherner M, Letendre SL, Kaul M, Grant I, and the TMARC Group.  (2020). Methamphetamine and cannabis: A tale of two drugs and their effects on HIV, brain, and behavior. Journal of Neuroimmune Pharmacology, Epub Sept 15. PMID: 32929575  
Ellis RJ, Peterson SN, Li Y, Schrier R, Iudicello J, Letendre S, Morgan E, Tang B, Grant I, Cherner M.  (2020). Recent cannabis use in HIV is associated with reduced inflammatory markers in CSF and blood. Neurology, Neuroimmunology & Neuroinflammation, 7(5), e809. PMID: 32554630  PMCID: PMC7309527  
Pocuca N, Young JW, MacQueen DA, Letendre S, Heaton RK, Geyer MA, Perry W, Grant I, Minassian A.  (2020). Sustained attention and vigilance deficits associated with HIV and a history of methamphetamine dependence. Drug And Alcohol Dependence, Epub Aug 22, 108245. PMID: 32871507  
Kohli M, Paolillo EW, Saloner R, Umlauf A Ellis R, Moore DJ.  (2020). The effects of low-risk drinking on neurocognition among older persons living with HIV as compared to those without HIV. Alcoholism, Clinical And Experimental Research, Epub May 25. PMID: 32449941  
Cherner M, Watson CW, Saloner R, Halpin LE, Minassian A, Murray SS, Vaida F, Bousman C, Everall I.  (2019). Adverse effect of catechol-O-methyltransferase (COMT) Val158Met met/met genotype in methamphetamine-related executive dysfunction. Addictive Behaviors, 98, 106023. PMID: 31301644  PMCID: PMC6733518  
Saloner R, Grelotti DJ, Tyree G, Sundermann EE, Ma Q, Letendre S, Heaton RK, Cherner M.  (2019). Benzodiazepine use is associated with an increased risk of neurocognitive impairment in people living with HIV. Journal of Acquired Immune Deficiency Syndromes (1999), 82(5), 475-482. PMID: 31714426  PMCID: PMC6857713  
Saloner R, Marquine MJ, Sundermann EE, Hong S, McCutchan JA, Ellis RJ, Heaton RK, Grant I, Cherner M.  (2019). COMT Val158Met polymorphism, cardiometabolic risk, and nadir CD4 synergistically increase risk for neurocognitive impairment in men living with HIV. Journal of Acquired Immune Deficiency Syndromes, 81(5), e148-e157. PMID: 31107306  
Saloner R, Paolillo EW, Umlauf A, Moore DJ, Heaton RK, Grant I, Cherner M.  (2019). Conditional effects of lifetime alcohol consumption on methamphetamine-associated neurocognitive performance. Journal of The International Neuropsychological Society, 25(8), 787-799. PMID: 31179969  PMCID: PMC6733657  
Kwiatkowski MA, Hellemann G, Sugar CA, Cope ZA, Minassian A, Perry W, Geyer MA, Young JW.  (2019). Dopamine transporter knockdown mice in the behavioral pattern monitor: A robust, reproducible model for mania-relevant behaviors. Pharmacology, Biochemistry, And Behavior, 178, 42-50. PMID: 29289701  
Basova L, Najera JA, Bortell N, Wang D, Moya R, Lindsey A, Semenova S, Ellis RJ, Marcondes MCG.  (2018). Dopamine and its receptors play a role in the modulation of CCR5 expression in innate immune cells following exposure to methamphetamine: Implications to HIV infection. PloS One, 13(6), e0199861. PMID: 29944719  
Boutros N, Der-Avakian A, Kesby JP, Lee S, Markou A, Semenova S.  (2018). Effects of adolescent alcohol exposure on stress-induced reward deficits, brain CRF, monoamines and glutamate in adult rats. Psychopharmacology, 235(3), 737-747. PMID: 29181815  
Kesby JP, Fields JA, Chang A, Coban H, Achim CL, Semenova S.  (2018). Effects of HIV-1 TAT protein and methamphetamine exposure on visual discrimination and executive function in mice. Behavioural Brain Research, 349, 73-79. PMID: 29709610  
Kesby JP, Chang A, Markou A, Semenova S.  (2018). Modeling human methamphetamine use patterns in mice: Chronic and binge methamphetamine exposure, reward function and neurochemistry. Addiction Biology, 23(1), 206-218. PMID: 28224681  PMCID: PMC5565728  
Hall M, Hauson A, Wollman S, Allen K, Connors E, Stern M, Kimmel C, Stephan R, Sarkissians S, Barlet B, Grant I.  (2018). Neuropsychological comparisons of cocaine versus methamphetamine users: A research synthesis and meta-analysis. The American Journal of Drug And Alcohol Abuse, 44(3), 277-293. PMID: 28825847  
Geyer MA, Semenova S, Li X, Der-Avakian A, Barnes SA, Grant I.  (2018). Overview of the biography and legacy of Professor Athina Markou. Biological Psychiatry, 83(11), 910-912. PMID: 29501205  
Thaney VE, Sanchez AB, Fields JA, Minassian A, Young JW, Maung R, Kaul M.  (2018). Transgenic mice expressing HIV-1 envelope protein Gp120 in the brain as an animal model in NeuroAIDS research. Journal of Neurovirology, 24(2), 156-167. PMID: 29075998  PMCID: PMC5911244  
Bischoff-Grethe A, Connolly CG, Jordan SJ, Brown GG, Paulus MP, Tapert SF, Heaton RK, Woods SP, Grant I.  (2017). Altered reward expectancy in individuals with recent methamphetamine dependence. Journal of Psychopharmacology (Oxford, England), 31(1), 17-30. PMID: 27649775  PMCID: PMC5225125  
Bortell N, Basova L, Semenova S, Fox HS, Ravasi T, Marcondes M.  (2017). Astrocyte-specific overexpressed gene signatures in response to Methamphetamine exposure in vitro. Journal of Neuroinflammation, 14(1), 49. PMID: 28279172  PMCID: PMC5345234  
Minassian A, Henry BL, Iudicello JE, Morgan EE, Letendre SL, Heaton RK, Perry W.  (2017). Everyday functional ability in HIV and methamphetamine dependence. Drug And Alcohol Dependence, 175, 60-66. PMID: 28399475  
Kesby JP, Najera JA, Romoli B, Fang Y, Basova L, Birmingham A, Marcondes MCG, Dulcis D, Semenova S.  (2017). HIV-1 TAT protein enhances sensitization to methamphetamine by affecting dopaminergic function. Brain, Behavior, And Immunity, 65, 210-221. PMID: 28495611  PMCID: PMC5537017  
Sanchez AB, Kaul M.  (2017). Neuronal stress and injury caused by HIV-1, CART and drug abuse: Converging contributions to HAND. Brain Sciences, 7(3). PMID: 28241493  PMCID: PMC5366824  
Kaul M.  (2017). The 23rd Scientific Conference of the Society on Neuroimmune Pharmacology. Journal of Neuroimmune Pharmacology : The Official Journal of The Society On NeuroImmune Pharmacology, 12(Suppl 1), 1-2. PMID: 28286912  
Hoenigl Mn, Oliveira M, Perez-Santiago J, Zhang Y, Morris S, McCutchan J, Finkelman M, Marcotte T, Ellis R, Gianella S.  (2016). (1→3)-β-D-Glucan Levels Correlate With Neurocognitive Functioning in HIV-Infected Persons on Suppressive Antiretroviral Therapy: A Cohort Study. Medicine, 95(11), e3162. PMID: 26986173  PMCID: PMC4839954  
Casaletto KB, Moore DJ, Woods SP, Umlauf A, Scott JC, Heaton RK.  (2016). Abbreviated goal management training shows preliminary evidence as a neurorehabilitation tool for HIV-associated neurocognitive disorders among substance users. The Clinical Neuropsychologist, 30(1), 107-130. PMID: 26753986  PMCID: PMC4801659  
Minassian A, Young JW, Cope ZA, Henry BL, Geyer MA, Perry W.  (2016). Amphetamine increases activity but not exploration in humans and mice. Psychopharmacology, 233(2), 225-233. PMID: 26449721  PMCID: PMC4703551  
Soontornniyomkij V, Kesby JP, Morgan EE, Bischoff-Grethe A, Minassian A, Brown GG, Grant I.  (2016). Effects of HIV and Methamphetamine on brain and behavior: Evidence from human studies and animal models. Journal of Neuroimmune Pharmacology : The Official Journal of The Society On NeuroImmune Pharmacology, 11(3), 495-510. PMID: 27484318  PMCID: PMC4985024  
Kesby PJ, Markou A, Semenova S, and the TMARC Group.  (2016). Effects of HIV/TAT protein expression and chronic selegiline treatment on spatial memory, reversal learning and neurotransmitter levels in mice. Behavioral Brain Research, 311, 131-140. PMID: 27211061  
Bharti AR, Woods SP, Ellis RJ, Cherner M, Rosario D, Potter M, Heaton RK, Everall IP, Masliah E, Grant I, Letendre SL.  (2016). Fibroblast Growth Factors 1 And 2 in cerebrospinal fluid are associated with HIV disease, methamphetamine use, and neurocognitive functioning. HIV/AIDS (Auckland, N.Z.), 8, 93-9. PMID: 27199571  PMCID: PMC4857802  
Joseph J, Cinque P, Colosi D, Dravid A, Ene L, Fox H, Gabuzda D, Gisslen M, Beth J, Letendre S, Mukerji SS, Nath A, Perez-Valero I, Persaud D, Price RW, Rao VR, Sacktor N, Swanstrom R, Winston A, Wojna V, Wright E, Spudich S.  (2016). Highlights of the global HIV-1 CSF Escape Consortium Meeting, 9 June 2016, Bethesda, MD, USA. Journal of Virus Eradication, 2(4), 243-250. PMID: 27781109  PMCID: PMC5075354  
Soontornniyomkij V, Umlauf A, Soontornniyomkij B, Batki IB, Moore DJ, Masliah E, Achim CL.  (2016). Lifetime Methamphetamine dependence is associated with cerebral microgliosis in HIV-1-infected adults. Journal of Neurovirology, 22(5), 650-660. PMID: 27098516  PMCID: PMC5055415  
McKenna B, Brown G, Archibald S, Scadeng M, Bussell R, Kesby J, Markou A, Soontornniyomkij V, Achim C, Semenova S, and the TMARC Group.  (2016). Microstructural changes to the brain of mice after methamphetamine exposure as identified with diffusion tensor imaging. Psychiatry Research, 249, 27-37. PMID: 27000304  PMCID: PMC4831583  
Var SR, Day TRC, Vitomirov A, Smith DM, Soontornniyomkij V, Moore DJ, Achim CL, Mehta SR, Perez-Santiago J.  (2016). Mitochondrial injury and cognitive function in HIV infection and methamphetamine use. AIDS (London, England), 30(6), 839-848. PMID: 26807965  PMCID: PMC475088  
Kamat R, Doyle KL, Iudicello JE, Morgan EE, Morris S, Smith D, Little S, Grant I, Letendre SL, Woods SP, and the TMARC Group.  (2016). Neurobehavioral disturbances in acute and early HIV infection. Cognitive and Behavioral Neurology, 29(1), 1-10. PMCID: PMC4806542  
 Morgan EE, Iudicello JE, Doyle KL, Weber E, Woods SP.  (2016). Neuropsychological aspects of methamphetamine use disorders and HIV disease. VR Preedy (Eds.), The Neuropathology of Drug Addictions and Substance Misuse. .
Kesby JP, Markou A, Semenova S.  (2016). The effects of HIV-1 regulatory TAT protein expression on brain reward function, response to psychostimulants and delay-dependent memory in mice. Neuropharmacology, 109, 205-215. PMID: 27316905  PMCID: PMC4970920  
Montoya JL, Cattie J, Morgan E, Woods SP, Cherner M, Moore DJ, Atkinson JH, Grant I, and the TMARC Group.  (2016). The impact of age, HIV serostatus and seroconversion on methamphetamine use. The American Journal of Drug And Alcohol Abuse, 42(2), 168-177. PMID: 26837461  PMCID: PMC4842208  
Marquine MJ, Montoya JL, Umlauf A, Fazeli PL, Gouaux B, Heaton RK, Ellis RJ, Letendre SL, Grant I, Moore DJ, and the HNRP Group.  (2016). The Veterans Aging Cohort Study (VACS) Index and neurocognitive change: A longitudinal study. Clinical Infectious Diseases : An Official Publication of The Infectious Diseases Society of America, 63(5), 694-702. PMID: 27199461  PMCID: PMC4981756  
Hoenigl M, Chaillon A, Moore DJ, Morris SR, Smith DM, Little SJ.  (2015). Clear links between starting methamphetamine and increasing sexual risk behavior: A cohort study among men who have sex with men. Journal of Acquired Immune Deficiency Syndromes (1999), 71(5), 551-557. PMID: 26536321  PMCID: PMC4788567  
Kesby JP, Markou A, Semenova S, Grant I, and the TMARC Group.  (2015). Cognitive deficits associated with combined HIV Gp120 expression and chronic methamphetamine exposure in mice. European Neuropsychopharmacology : The Journal of The European College of Neuropsychopharmacology, 25(1), 141-150. PMID: 25476577  PMCID: PMC4289653  
Hoefer MM, Sanchez AB, Maung R, de Rozieres CM, Catalan IC, Dowling CC, Thaney VE, Piña-Crespo J, Zhang D, Roberts AJ, Kaul M.  (2015). Combination of Methamphetamine and HIV-1 Gp120 causes distinct long-term alterations of behavior, gene expression, and injury in the central nervous system. Experimental Neurology, 263, 221-234. PMID: 25246228  PMCID: PMC4370186  
Casaletto KB, Obermeit L, Morgan EE, Weber E, Franklin DR, Grant I, Woods SP; the TMARC Group.  (2015). Depression and executive dysfunction contribute to a metamemory deficit among individuals with methamphetamine use disorders. Addictive Behaviors, 40, 45-50. PMID: 25222847  PMCID: PMC4250506  
Ipser JC, Brown GG, Bischoff-Grethe A, Connolly CG, Ellis RJ, Heaton RK, Grant I.  (2015). HIV infection is associated with attenuated frontostriatal intrinsic connectivity: A preliminary study. Journal of The International Neuropsychological Society : JINS, 21(3), 203-13. PMID: 25824201  PMCID: PMC4400233  
Kamat R, Cattie JE, Marcotte TD, Woods SP, Franklin DR, Corkran SH, Ellis RJ, Grant I, Heaton RK.  (2015). Incident major depressive episodes Increase The severity and risk of apathy in HIV infection. Journal of Affective Disorders, 175C, 475-480. PMID: 25679203  PMCID: PMC4386921  
Li X, Markou A.  (2015). Metabotropic Glutamate Receptor 7 (mGluR7) as a target for the treatment of psychostimulant dependence. CNS & Neurological Disorders Drug Targets, 14(6), 738-744. PMID: 26022263  PMCID: PMC4562387  
Kesby JP, Heaton RK, Young JW, Umlauf AA, Woods SP, Letendre S, Markou A, Grant I, Semenova S.  (2015). Methamphetamine exposure combined with HIV-1 disease or gp120 expression: Comparison of learning and executive function in humans and mice. Neuropsychopharmacology, 40(8), 1899-1909. PMID: 25652249  
Massanella M, Gianella S, Schrier R, Dan JM, Perez-Santiago J, Oliveira MF, Richman DD, Little SJ, Benson CA, Daar ES, Dube MP, Haubrich RH, Smith DM, Morris SR.  (2015). Methamphetamine use in HIV-infected individuals affects T-cell function and viral outcome during suppressive antiretroviral therapy. Scientific Reports, 5, 13179. PMID: 26299251  PMCID: PMC4547398  
Morgan EE, Iudicello JE, Cattie JE, Blackstone K, Grant I, Woods SPl.  (2015). Neurocognitive impairment is associated with lower health literacy among persons living with HIV infection. AIDS And Behavior, 19(1), 166-177. PMID: 25008384  PMCID: PMC4289466  
Cattie JE, Marquine MJ, Bolden KA, Obermeit L, Morgan EE, Franklin DR, Umlauf A, Beck JM, Atkinson JH, Grant I, Woods SP and the TMARC Group.  (2015). Predictors of attrition in a cohort study of HIV infection and methamphetamine dependence. Journal of Substance Use, 20(6), 407-416. PMID: 26752974  PMCID: PMC4704691  
Bousman CA, McKetin R, Burns R, Woods SP, Morgan EE, Atkinson JH, Everall IP, Grant I, and the TMARC Group.  (2015). Typologies of positive psychotic symptoms in methamphetamine dependence. Psychiatry and Clinical Neuroscience, 24(2), 94-97. PMID: 25864598  PMCID: PMC4369467  
Marquine MJ, Iudicello JE, Morgan EE, Brown GG, Letendre SL, Ellis RJ, Deutsch R, Woods SP, Grant I, Heaton RK.  (2014). "Frontal Systems" behaviors in comorbid human immunodeficiency virus infection and methamphetamine dependency. Psychiatry Research, 215(1), 208-216. PMID: 24290100  PMCID: PMC3967865  
Connolly CG, Bischoff-Grethe A, Jordan SJ, Woods SP, Ellis RJ, Paulus MP, Grant I.  (2014). Altered functional response to risky choice in HIV infection. PloS One, 9(10), e111583. PMID: 25347679  PMCID: PMC4210250  
Kamat R, Brown GG, Bolden K, Fennema-Notestine C, Archibald S, Marcotte TD, Letendre SL, Ellis RJ, Woods SP, Grant I, Heaton RK.  (2014). Apathy is associated with white matter abnormalities in anterior, medial brain regions in persons with HIV infection. Journal of Clinical And Experimental Neuropsychology, 36(8), 854-866. PMID: 25275424  PMCID: PMC4303236  
 Cattie J, Grant I.  (2014). Cannabis. In DN Allen and SP Woods (Eds.), Neuropsychological Aspects of Substance Use Disorders. , (pp. 134-156). New York: Oxford University Press.
Morgan EE, Doyle KL, Minassian A, Henry BL, Perry W, Marcotte TD, Woods SP, Grant I.  (2014). Elevated intraindividual variability in methamphetamine dependence is associated with poorer everyday functioning. Psychiatry Research, 220(1-2), 527-534. PMID: 25081313  PMCID: PMC4252574  
Desplats P, Dumaop W, Cronin P, Gianella S, Woods S, Letendre S, Smith D, Masliah E, Grant I.  (2014). Epigenetic alterations in the brain associated with HIV-1 infection and methamphetamine dependence. PloS One, 9(7), e102555. PMID: 25054922  PMCID: PMC4108358  
 Scott J, Blackstone K, Marcotte T.  (2014). Everyday Functioning in Substance Use Disorders. D. N. Allen & S.P. Woods (Eds.), Neuropsychological aspects of substance use disorders: Evidence-based perspectives. , (pp. 364-389). Oxford University Press.
Kesby JP, Hubbard DT, Markou A, Semenova S.  (2014). Expression of HIV Gp120 protein increases sensitivity to the rewarding properties of Methamphetamine in mice. Addiction Biology, 19(4), 593-605. PMID: 23252824  PMCID: PMC3608835  
 Loftis J, Huckans M, Weber E, and Woods SP.  (2014). Infectious disease & substance use disorder comorbidity. D.N. Allen & S.P. Woods (Eds.), Neuropsychological aspects of substance use disorders: Evidence-based perspectives. , (pp. 310-340). Oxford University Press.
 Iudicello JE, Bolden KA, Griglak SR, and Woods SP.  (2014). Methamphetamine. D. N. Allen & S.P. Woods (Eds.), Neuropsychological aspects of substance use disorders: Evidence-based perspectives. Oxford University Press.
Cattie JE, Letendre SL, Woods SP, Barakat F, Perry W, Cherner M, Umlauf A, Franklin D, Heaton RK, Hassanein T, Grant I.  (2014). Persistent neurocognitive decline in a clinic sample of Hepatitis C virus-infected persons receiving Interferon and Ribavirin treatment. Journal of Neurovirology, 20(6), 561-570. PMID: 25326107  PMCID: PMC4367690  
Henry BL, Geyer MA, Buell MR, Perry W, Young JW, Minassian A.  (2014). Prepulse inhibition in HIV-1 Gp120 transgenic mice after withdrawal from chronic methamphetamine. Behavioural Pharmacology, 25(1), 12-22. PMID: 24281153  PMCID: PMC3926694  
Montoya JL, Georges S, Poquette A, Depp CA, Atkinson JH, Moore DJ.  (2014). Refining a personalized mHealth intervention to promote medication adherence among HIV+ methamphetamine users. AIDS Care, 26(12), 1477-1481. PMID: 24911433  PMCID: PMC4188758  
Obermeit LC, Cattie JE, Bolden KA, Marquine MJ, Morgan EE, Franklin DR, Atkinson JH, Grant I, Woods SP, and the TMARC Group.  (2013). Attention-Deficit/Hyperactivity Disorder among chronic methamphetamine users: Frequency, persistence, and adverse effects on everyday functioning. Addictive Behaviors, 38(12), 2874-2878. PMID: 24018233  PMCID: PMC3805791  
Henry BL, Geyer MA, Buell MR, Perry W, Young JW, Minassian A.  (2013). Behavioral effects of chronic methamphetamine treatment in HIV-1 gp120 transgenic mice. Behavioural Brain Research, 236(1), 210-220. PMID: 22960458  PMCID: PMC3482284  
Morris S, Woods SP, Deutsch R, Little SJ, Wagner G, Morgan EE, Heaton RK, Letendre SL, Grant I, Smith DM and the TMARC Group.  (2013). Dual-mixed HIV-1 co-receptor tropism is associated with HIV associated neurocognitive dysfunction. Journal of NeuroVirology, 19(5), 488-494. PMID: 24078557  PMCID: PMC3921071  
Montoya JL, Umlauf A, Abramson I, Badiee J, Woods SP, Atkinson JH, Grant I, Moore DJ, and the TMARC Group.  (2013). Dynamic indices of methamphetamine dependence and HIV infection predict fluctuations in affective distress: A five-year longitudinal analysis. Journal of Affective Disorders, 151(2), 728-737. PMID: 24012068  PMCID: PMC3845675  
Blackstone K, Iudicello JE, Morgan EE, Weber E, Moore DJ, Franklin D, Ellis RJ, Grant I, Woods SP, and the TMARC Group.  (2013). HIV infection heightens concurrent risk of functional dependence in persons with chronic methamphetamine use. Journal of Addiction Medicine, 7(4), 255-263. PMID: 23648641  PMCID: PMC3737384  
Cherner M.  (2013). Introduction to current issues in HIV-associated neurocognitive disorders (HAND). APA Psychology and AIDS Exchange Newsletter, January
Tatro ET, Hefler S, Shumaker-Armstrong S, Soontornniyomkij B, Yang M, Yermanos A, Wren N, Moore DJ, Achim CL.  (2013). Modulation of BK channel by MicroRNA-9 in neurons after exposure to HIV and Methamphetamine. Journal of Neuroimmune Pharmacology : The Official Journal of The Society On NeuroImmune Pharmacology, 8(5), 1210-1223. PMID: 23508624  PMCID: PMC3715589  
Minassian A, Henry BL, Woods SP, Vaida F, Grant I, Geyer MA, Perry W, the TMARC Group.  (2013). Prepulse inhibition in HIV-associated neurocognitive disorders. Journal of the International Neuropsychological Society, 19(6), 709-717. PMID: 23552464  PMCID: PMC3729041  
Weber E, Morgan EE, Iudicello JE, Blackstone K, Grant I, Ellis RJ, Letendre SL, Little S, Morris S, Smith DM, Moore DJ, Woods SP, and the TMARC Group.  (2013). Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection. Journal of NeuroVirology, 19(1), 65-74. PMID: 23250704  PMCID: PMC3568179  
Cherner M.  (2013). The HIV+ brain on drugs: Focus on methamphetamine. APA Psychology and AIDS Exchange Newsletter, January
Soontornniyomkij V, Moore DJ, Gouaux B, Soontornniyomkij B, Tatro ET, Umlauf A, Masliah E, Levine AJ, Singer EJ, Vinters HV, Gelman BB, Morgello S, Cherner M, Grant I, Achim CL.  (2012). Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers. AIDS (London, England), 26(18), 2327-2335. PMID: 23018443  PMCID: PMC3576852  
Cattie JE, Woods SP, Iudicello JE, Posada C, Grant I, and the TMARC Group.  (2012). Elevated neurobehavioral symptoms are associated with poorer everyday functioning problems in chronic methamphetamine users. Journal of Neuropsychiatry and Clinical Neurosciences, 24(3), 331-339. PMID: 23037647  PMCID: PMC3735421  
Archibald SL, Jacobson MW, Fennema-Notestine C, Ogasawara M, Woods SP, Letendre S, Grant I, Jernigan TL.  (2012). Functional interactions of HIV-infection and methamphetamine dependence during motor programming. Psychiatry Research, 202(1), 46-52. PMID: 22608157  PMCID: PMC3380171  
Maung R, Medders KE, Sejbuk NE, Desai MK, Russo R, Kaul M.  (2012). Genetic knockouts suggest a critical role for HIV co-receptors in models of HIV gp120-induced brain injury. Journal of Neuroimmune Pharmacology, 7, 306-318. PMID: 22124968  PMCID: PMC3690779  
Reid E, Morris SR.  (2012). HIV Co-receptor usage in HIV-related non-hodgkin's lymphoma. Infectious Agents and Cancer, 7(1), 6. PMID: 22420651  PMCID: PMC3338399  
Moore DJ, Blackstone K, Woods SP, Ellis RJ, Atkinson JH, Heaton RK, Grant I, the HNRC Group and the TMARC Group.  (2012). Methamphetamine use and neuropsychiatric factors are associated with antiretroviral nonadherence. AIDS Care, 24(12), 1504-1513. PMID: 22530794  PMCID: PMC3466384  
Weber E, Blackstone K, Iudicello JE, Morgan EE, Grant I, Moore DJ, Woods SP, and the TMARC Group.  (2012). Neurocognitive deficits are associated with unemployment in chronic methamphetamine users. Drug and Alcohol Dependence, 125(1-2), 146-153. PMID: 22560676  PMCID: PMC3735422  
Pottiez G, Jagadish T, Yu F, Letendre S, Ellis R, Duarte NA, Grant I, Gendelman H, Fox HS, Ciborowski P.  (2012). Plasma proteomic profiling in HIV-1 infected methamphetamine abusers. PLOS One, 7(2), e31031. PMID: 22359561  PMCID: PMC3281056  
Morgan EE, Woods SP, Poquette AJ, Vigil O, Heaton RK, Grant I, and the TMARC Group.  (2012). Visual memory in methamphetamine dependent individuals: Deficient strategic control of encoding and retrieval. Australian and New Zealand Journal of Psychiatry, 46(2), 141-152. PMID: 22311530  PMCID: PMC3278859  
Duarte N, Woods SP, Rooney A, Grant I, Atkinson JA, and the TMARC Group.  (2012). Working memory deficits affect risky decision-making in methamphetamine users with Attention-Deficit/Hyperactivity Disorder. Journal of Psychiatric Research, 46, 492-499. PMID: 22305489  PMCID: PMC330787  
Gupta S, Bousman CA, Chana G, Cherner M, Heaton RK, Deutsch R, Ellis RJ, Grant I, Everall IP.  (2011). Dopamine receptor D3 genetic polymorphism (rs6280TC) is associated with rates of cognitive impairment in methamphetamine-dependent men with HIV: preliminary findings. Journal of NeuroVirology, 17(3), 239-247. PMID: 21491142  PMCID: PMC3151555  
Henry BL, Minassian A, van Rhenen M, Young JW, Geyer MA, Perry W, and the TMARC Group.  (2011). Effect of Methamphetamine dependence on inhibitory deficits in a novel human open-field paradigm. Psychopharmacology, 215(4), 697-707. PMID: 21279333  PMCID: PMC3102201  
Ances BM, Vaida F, Cherner M, Yeh MJ, Liang CL, Gardner C, Grant I, Ellis RJ, Buxton RB, and the HNRC Group.  (2011). HIV and chronic methamphetamine dependence affect cerebral blood flow. Journal of Neuroimmune Pharmacology, 6(3), 409-19. PMID: 21431471  PMCID: PMC325131  
Iudicello JE, Weber E, Dawson M, Grant I, Weinborn M, Woods SP, and the HNRC Group.  (2011). Misremembering future intentions in methamphetamine dependent individuals. The Clinical Neuropsychologist, 25, 269-286. PMID: 21331980  PMCID: PMC3264429  
Bousman CA, Cherner M, Atkinson JH, Heaton RK, Grant I, Everall IP, and the HNRC Group.  (2010). COMT Val158Met Polymorphism, Executive Dysfunction, and Sexual Risk Behavior in the Context of HIV Infection and Methamphetamine Dependence. Interdisciplinary Perspectives on Infectious Disease, Epub Jan 3. PMID: 20069120  PMCID: PMC2804107  
Cherner M, Bousman C, Everall I, Barron D, Letendre S, Vaida F, Atkinson JH, Heaton R, Grant I, and the HNRC Group.  (2010). Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: Preliminary findings. Journal of the International Neuropsychological Society, 16(5), 890-901. PMID: 20727252  PMCID: PMC3543816  
Morris SR, Little SJ, Cunningham T, Garfein RS, Richman DD, Smith DM.  (2010). Evaluation of an HIV nucleic acid testing program with automated internet and voicemail systems to deliver results. Ann Intern Med, 152(12), 778-85. PMID: 20547906  
Bousman CA, Cherner M, Atkinson JH, Grant I, Tsuang MT, Everall IP.  (2010). Impact of the Catechol-O-Methyltransferase VAL158Met Polymorphism on executive functioning in the context of HIV-infection and methamphetamine dependence. Neurobehavioral HIV Medicine, , 1-11. PMID: 24078782  PMCID: PMC3782745  
Iudicello JE, Woods SP, Vigil O, Cobb SJ, Cherner M, Heaton RK, Atkinson JH, Grant I, and the HNRC Group.  (2010). Longer term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence. Journal of Clinical and Experimental Neuropsychology, 32(7), 704-718. PMID: 20198527  PMCID: PMC2911490  
Cherner M, Suarez P, Casey C, Deiss R, Letendre S, Marcotte T, Vaida F, Atkinson JH, Grant I, Heaton RK, and the HNRC Group.  (2010). Methamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults. Drug and Alcohol Dependence, 106, 154-163. PMID: 19815352  PMCID: PMC2814900  
Bousman CA, Glatt SJ, Cherner M, Atkinson JH, Grant I, Tsuang MT, Everall IP, and the HNRC Group.  (2010). Preliminary evidence of ethnic divergence in associations of putative genetic variants for methamphetamine dependence. Psychiatry Research, 178(2), 295-298. PMID: 20478633  PMCID: PMC2902702  
Bousman CA, Cherner M, Emory KT, Barron D, Grebenstein P, Atkinson JH, Heaton RK, Grant I, and the HNRC Group.  (2010). Preliminary evidence of motor impairment among polysubstance 3,4-methylenedioxymethamphetamine users with intact neuropsychological functioning. Journal of The International Neuropsychological Society : JINS, 16(6), 1047-1055. PMID: 20735886  PMCID: PMC3737074  
Gonzalez R, Cherner M.  (2008). Co-factors in HIV neurobehavioural disturbances: substance abuse, Hepatitis C and aging. International Review of Psychiatry (Abingdon, England), 20(1), 49-60. PMID: 18240062